Progress of Digestive Endoscopy
Online ISSN : 2187-4999
Print ISSN : 1348-9844
ISSN-L : 1348-9844
Clinical study
The usefulness of l-menthol as an antispasmodic drug during ERCP
Masatoshi MabuchiTakako AdachiTakeshi OndaHanae KajiyamaKotaro MatsumotoKatsunori SekineTakayuki TsujikawaNoritaka OzawaYusuke KajiyamaShinpei DoiKoichiro SatoKentaro KikuchiIchiro Yasuda
Author information
Keywords: ERCP, l-menthol
JOURNAL FREE ACCESS

2016 Volume 89 Issue 1 Pages 70-71

Details
Abstract

Background : A risk factor during endoscopic retrograde cholangiopancreatography (ERCP) is peristalsis of the duodenum. Common antispasmodic drugs such as scopolamine butylbromide and glucagon are associated with a risk of complications in patients with heart, prostate, diabetes mellitus, and thyroid disease. l-menthol has an antispasmodic effect on the smooth muscles of the stomach, bowel, and colon.
Methods : We prospectively evaluated ERCP without gastrectomy at Teikyo University Mizonokuchi Hospital, between July 2014 and March 2016.
Results : The total number of eligible patients was 359. The complete procedure rate with l-menthol alone was 90.5%. The median total procedure time was 23 seconds. In almost 80% of cases, appropriate peristalsis of duodenum for ERCP l-menthol alone was observed.
Conclusion : We propose that l-menthol can be useful as an antispasmodic drug during ERCP.

Content from these authors
© 2016 Japan Gastroenterological Endoscopy Society Kanto Chapter
Previous article Next article
feedback
Top